Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00006341 · ClinicalTrials.gov registry record · Phase 2

Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer

A Phase 2 study of Head and Neck Cancer, sponsored by Jonsson Comprehensive Cancer Center.

Completed
Registry status
Phase 2
Development phase
46
Enrollment target
1
Study location

NCT00006341: Completed Phase 2 study of Head and Neck Cancer, sponsored by Jonsson Comprehensive Cancer Center.

NCT00006341 is a Phase 2 study of Head and Neck Cancer that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 46 participants, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00006341, a Phase 2 study of Head and Neck Cancer, has completed, sponsored by Jonsson Comprehensive Cancer Center.

COMPLETED
Registry status
Phase 2
Development phase
46 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: The use of dentures and dental implants may help maintain chewing and speaking ability following surgery to remove tumors in the mouth. PURPOSE: Phase II trial to study the effectiveness of dentures and dental implants in maintaining the ability to chew and speak in patients undergoing surgery for mouth cancer.

Conditions Studied

Head and Neck Cancer

Interventions

  • OTHER Implant

Study Locations (1)

California

  • Jonsson Comprehensive Cancer Center, UCLA - Los Angeles

Trial Details

FieldValue
Enrollment Target 46 participants
Start Date 1997-06
Est. Completion 2003-05
Phase Phase 2
Jonsson Comprehensive Cancer Center

321 total trials

What the finished NCT00006341 record still lists

NCT00006341 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 46 participants, a relatively small participant target, below the 261-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Head and Neck Cancer appearing as the primary indexed condition, and to 1 intervention - of which Implant is the first listed.

NCT00006341 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00006341 about?

NCT00006341 is a clinical study titled "Dentures and Dental Implants in Treating Patients Undergoing Surgery for Mouth Cancer". RATIONALE: The use of dentures and dental implants may help maintain chewing and speaking ability following surgery to remove tumors in the mouth. PURPOSE: Phase II trial to study the effectiveness of dentures and dental implants in maintaining the ability to chew and speak in patients undergoing s...

What is the current status of trial NCT00006341?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 46 participants. The study started on 1997-06. Estimated completion is 2003-05.

What conditions does trial NCT00006341 study?

This clinical trial studies the following conditions: Head and Neck Cancer.

What interventions are being tested in trial NCT00006341?

The interventions under investigation include: Implant (OTHER).

Who is sponsoring clinical trial NCT00006341?

This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00006341 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00006341's enrollment target sits among peer trials

46 136th of 250 higher than 115 of 250 other Head and Neck Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Head and Neck Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01890590 · 46 participants · NA

    A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma

  • NCT03191149 · 46 participants · Phase 2

    Testing Osimertinib as a Treatment for Lung Cancers With an EGFR Exon 20 Change

  • NCT03510208 · 46 participants · Phase 1

    Panitumumab-IRDye800 in Diagnosing Participants With Malignant Glioma Undergoing Surgery

  • NCT04048278 · 46 participants · Early Phase 1

    Lidocaine Infusion in Pancreatic Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Related registry views

Source: ClinicalTrials.gov NCT00006341, the US trial registry maintained by the National Library of Medicine. NCT00006341 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.